Full name
CENTRUM NOWOCZESNYCH TERAPII "DOBRY LEKARZ" SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
72.19.Z - Scientific research and development activities
70.10.Z - Head office activities
70.22.Z - Head office activities and management consultancy
72.11.Z - Scientific research and development activities
72.20.Z - Scientific research and development in social sciences and humanities
82.99.Z - Other business support activities, not elsewhere classified
85.5 - Non-school forms of education
85.6 - Educational support activities
86.2 - Medical and dental practices
86.9 - Other healthcare activities
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | -0,2 | 0,5 | 0,7 | 34,6 |
EBITDA | -0,1 | 0,5 | 0,8 | 41,8 |
Short time liabilities | 0,2 | 0,3 | 0,3 | -7,1 |
Equity capital | 0,3 | 0,8 | 1,3 | 68,1 |
Operating profit (EBIT) | -0,1 | 0,5 | 0,8 | 43 |
Assets | 0,5 | 1,1 | 1,6 | 48,5 |
Net profit (loss) | -0,2 | 0,5 | 0,6 | 31,6 |
Cash | 0,2 | 0,4 | 0,6 | 37,5 |
Net income from sale | 1,6 | 2,4 | 3,3 | 37,9 |
Liabilities and provisions for liabilities | 0,2 | 0,3 | 0,3 | -7,1 |
Working assets | 0,4 | 0,9 | 1,3 | 36,9 |
Depreciation | 0 | 0 | 0 | 9,8 |
% | % | % | p.p. | |
Profitability of capital | -49,5 | 61,4 | 48 | -13,4 |
Equity capital to total assets | 61,5 | 73,9 | 83,6 | 9,7 |
Gross profit margin | -9,4 | 21,7 | 21,2 | -0,5 |
EBITDA Margin | -8,1 | 22,5 | 23,1 | 0,6 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 42 | 42 | 29 | -13 |
Current financial liquidity indicator | 2.062110424041748 | 3.299185276031494 | 4.861374855041504 | 1,6 |
Net dept to EBITDA | 1.050642728805542 | -0.8091740012168884 | -0.784444272518158 | 0 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane